Andrea Cipriani

Profile photo of Andrea Cipriani
After 10 years at the University of Verona as Lecturer in Psychiatry, Andrea is now working in Oxford. His main interest in psychiatry is evidence-based mental health and his research focuses on the evaluation of treatments in psychiatry, mainly major depression, bipolar disorder and schizophrenia. He has carried out many systematic reviews, meta-analyses and randomised controlled trials in psychopharmacology, however in the past few years he has also been investigating relevant issues in epidemiological psychiatry and public health, like patterns of drug consumption, risk of serious adverse events (most of all, suicide and deliberate self harm) and implementation of treatment guidelines. His interest in the methodology of evidence synthesis has now a specific focus on network meta-analysis and individual patient data meta-analysis, trying to assess the validity, breadth, structure and interpretation of these statistical approaches to better inform the mental healthcare decision-making process. He has been working closely with world class academic institutions (Universities of Bristol, Cambridge and York in the UK; Universities of Ulm and Munich in Germany; University of Ioannina in Greece; Universities of Nagoya and Kyoto in Japan; University of Cape Town in South Africa) and important organisations, such as the National Institute for Health and Clinical Excellence in the UK, the Istituto Superiore di Sanità in Italy and the World Health Organization (WHO) in Geneva. Together with the Department of Mental Health and Substance Abuse at WHO he has co-authored a manual on psychopharmacology, which provided evidence-based information to health care professionals in primary care especially in low- and middle-income countries. This manual is part of the Gap Action Programme of the WHO and is distributed by WHO as a reference source to assist physicians working in the primary health care through increasing their knowledge and improving their routine clinical practice in using evidence-based medicines for mental disorders. He is currently Editor in Chief of Evidence-Based Mental Health. He is also on the Editorial Boards of The Lancet Psychiatry and the Australian and New Zealand Journal of Psychiatry and Bipolar Disorders. You can find Andrea on Twitter: @And_Cipriani


Follow me here –

Can network meta-analysis decide the best psychosocial intervention for bipolar disorder?


Guy Goodwin and Andrea Cipriani highlight a number of methodological concerns in a new network meta-analysis of psychosocial therapies for the adjunctive treatment of bipolar disorder.

[read the full story...]